Skip to main content
. 2016 Jun 24;90(14):6224–6234. doi: 10.1128/JVI.00038-16

FIG 4.

FIG 4

Antibody-mediated inhibition and enhancement of L2 cleavage. (A and B) L2 cleavage blot (A) and infectivity (B) of mock- or PSTCD-L2-infected HaCaT cells in the presence of L1-specific V5 and U4 MAbs, L2-specific K4 MAb, or control HA-specific MAb. (C) Titration curves of V5 neutralization of infection (solid line) and L2 cleavage (dotted line).